The 53BP1 Antibody Market is centered on antibodies targeting 53BP1 (p53‑binding protein 1), a key mediator in the DNA damage response and double‑strand break repair pathways. 53BP1 plays a crucial role in non‑homologous end joining (NHEJ) and influences repair pathway choice, impacting genome stability, immune receptor development, and responses to genotoxic therapies. Antibodies against 53BP1...